Related Experiment Video
Updated: May 24, 2026
09:08
Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies
Published on: May 24, 2021
Endothelin-1 and -2: two amino acids matter
Matthijs G Compeer1, Dennis P L Suylen, Tilman M Hackeng
1Department of Pharmacology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Life Sciences
|March 13, 2012
Summary
Endothelin-1 and endothelin-2 exhibit distinct interactions with endothelin(A) receptors, influenced by specific amino acids. This finding suggests potential for developing targeted antagonists for endothelin-related diseases.
Area of Science:
- Pharmacology
- Molecular Biology
- Cardiovascular Research
Background:
- Endothelin-1 (ET-1) and endothelin-2 (ET-2) are peptides with similar structures but potentially different receptor interactions.
- Endothelin receptors, particularly the ET(A) subtype, play crucial roles in regulating vascular tone.
- Understanding agonist-dependent receptor function is key to developing targeted therapies.
Purpose of the Study:
- To investigate the agonist-dependent characteristics of endothelin(A) (ET(A))-receptor function.
- To determine the role of amino acids at positions 6 and 7 in the differential pharmacology of ET-1 and ET-2.
- To compare the vasomotor responses mediated by ET-1, ET-2, and their chimeric forms on arterial smooth muscle.
Main Methods:
- Utilized isolated rat mesenteric resistance arteries mounted on wire myographs.
- Minimized the influence of endothelium and sensorimotor nerves to focus on smooth muscle responses.
- Assessed arterial smooth muscle ET(A)-receptor-mediated vasomotor responses to ET-1, ET-2, and specific chimeric peptides (Leu(7)ET-1, Trp(6)ET-1).
Main Results:
- ET-1 and ET-2 induced arterial contractions with comparable potency and maximal effects.
- The ET(A) antagonist BQ123 showed differential effects, being more potent in reducing ET-1 sensitivity but more effective in relaxing maximal ET-2 contractions.
- Leu(7)ET-1 acted as a contractile agonist with reduced potency versus ET-1, while Trp(6)ET-1 showed no contractile activity or antagonism at tested concentrations.
Conclusions:
- Arterial smooth muscle ET(A)-receptor function exhibits agonist-dependent properties.
- Amino acids at positions 6 and 7 of the endothelin sequence are critical for these differential effects.
- The findings support the development of specific, agonist-selective ET-receptor antagonists for treating endothelin-dependent pathologies.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
03:42Amino acids
Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...